Sophie Abgrall1, Julia Del Amo. 1. aCESP Inserm, U1018, Univ Paris-Sud, Université de Paris-Saclay, Le Kremlin-BicêtrebHôpital Antoine Béclère, Clamart, FrancecNational Center for EpidemiologydCIBERESP, Ciber of Epidemiology and Public Health, Institute of Health Carlos III, Madrid, Spain.
Abstract
PURPOSE OF REVIEW: The purpose is to describe and understand the sociodemographic determinants of survival in people living with HIV within high-income countries in the context of the current recommendation of universal antiretroviral therapy for all HIV-infected persons, irrespective of their CD4 cell count. RECENT FINDINGS: Survival rates in people living with HIV have experienced remarkable increases in the last decade because of more efficacious and well tolerated treatments. Still, these improvements are unevenly distributed between regions across the world as well as within regions. HIV outcomes are heavily influenced by what are known as the 'social determinants' of health which have traditionally encompassed the gender, race/ethnicity, and socioeconomic axes. The evidence that these social determinants are now more important than before (more and earlier interventions are now available), has become stronger in the last 2 years. SUMMARY: Because antiretroviral therapy is now recommended for all HIV-infected persons, sociodemographic factors limiting access to testing, treatment, and retention in care will undoubtedly jeopardize the UNAIDS aspirational objective to end AIDS by 2030. Innovative interventions targeting individuals with social vulnerability are urgently needed to ensure that social inequalities do not continue to be linked with higher mortality.
PURPOSE OF REVIEW: The purpose is to describe and understand the sociodemographic determinants of survival in people living with HIV within high-income countries in the context of the current recommendation of universal antiretroviral therapy for all HIV-infectedpersons, irrespective of their CD4 cell count. RECENT FINDINGS: Survival rates in people living with HIV have experienced remarkable increases in the last decade because of more efficacious and well tolerated treatments. Still, these improvements are unevenly distributed between regions across the world as well as within regions. HIV outcomes are heavily influenced by what are known as the 'social determinants' of health which have traditionally encompassed the gender, race/ethnicity, and socioeconomic axes. The evidence that these social determinants are now more important than before (more and earlier interventions are now available), has become stronger in the last 2 years. SUMMARY: Because antiretroviral therapy is now recommended for all HIV-infectedpersons, sociodemographic factors limiting access to testing, treatment, and retention in care will undoubtedly jeopardize the UNAIDS aspirational objective to end AIDS by 2030. Innovative interventions targeting individuals with social vulnerability are urgently needed to ensure that social inequalities do not continue to be linked with higher mortality.
Authors: Derek Larson; Seung Hyun Won; Anuradha Ganesan; Ryan C Maves; Karl Kronmann; Jason F Okulicz; Xiuping Chu; Christina Schofield; Thomas O'Bryan; Brian K Agan; Robert Deiss Journal: HIV Med Date: 2021-10-26 Impact factor: 3.180
Authors: Chodziwadziwa W Kabudula; Brian Houle; Mark A Collinson; Kathleen Kahn; Francesc Xavier Gómez-Olivé; Stephen Tollman; Samuel J Clark Journal: Lancet Glob Health Date: 2017-09 Impact factor: 26.763
Authors: Nana K Ayisi-Boateng; Anthony Enimil; Aliyu Mohammed; Akye Essuman; Henry Lawson; Douglas Opoku Aninng; David Agyemang-Yeboah; Kathryn Spangenberg Journal: Afr J Prim Health Care Fam Med Date: 2020-06-09
Authors: Jenna M Norton; Lindsay Grunwald; Amanda Banaag; Cara Olsen; Andrew S Narva; Eric Marks; Tracey P Koehlmoos Journal: Kidney Med Date: 2021-10-23
Authors: Laure-Amélie de Monteynard; Sophie Matheron; Sophie Grabar; Pierre de Truchis; Jacques Gilquin; Juliette Pavie; Odile Launay; Jean-Luc Meynard; Marie-Aude Khuong-Josses; David Rey; Aba Mahamat; Rosemarie Dray-Spira; Anne Simon; Dominique Costagliola; Sophie Abgrall Journal: PLoS One Date: 2018-10-31 Impact factor: 3.240